Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.50 |
| ▸ | FNTA | P49354 | 5/20 | 0.49 |
| ▸ | FNTB | P49356 | 3/20 | 0.49 |
| ▸ | SQLE | Q14534 | 3/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11304942 | 1.00 | ALOX15 (0.56) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL11304941 | 0.88 | KMT2A (0.60) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL3751818 | 0.84 | ALOX15 (0.56) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL3193242 | 0.84 | ALOX15 (0.56) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL3193249 | 0.84 | ALOX15 (0.56) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL12997108 | 0.84 | ALOX15 (0.56) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL3751814 | 0.84 | ALOX15 (0.56) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL11305912 | 0.81 | ALOX15 (0.53) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL27993750 | 0.79 | KMT2A (0.55) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL10385940 | 0.79 | KMT2A (0.65) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4254291-A | FORMING METAL ESTERS OR ALCOHOLATES, ISOMERIZATION AND HYDROLYSIS USING A TRANSITION METAL COMPOUND CATALYST | SCM CORPORATION (US) | 1981-03-03 | — | — | US | claimed |
| US-9587206-B2 | Combination of an amino alcohol, a fragrance and a silicic acid ester, and the use of same as a pro-fragrance | HENKEL AG & CO. KGAA (DE) | 2017-03-07 | — | — | US | disclosed |
| US-20140323375-A1 | COMBINATION OF AN AMINO ALCOHOL, A FRAGRANCE AND A SILICIC ACID ESTER, AND THE USE OF SAME AS A PRO-FRAGRANCE | HENKEL AG & CO. KGAA (DE) | 2014-10-30 | — | — | US | disclosed |
| US-20090099382-A1 | ACTIVE INGREDIENT CARRIERS WHICH ARE BASED ON SILICON AND CONTAIN AMINOALKYL GROUPS | HENKEL AG & CO. KGAA (DE) | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099382-A1 | ACTIVE INGREDIENT CARRIERS WHICH ARE BASED ON SILICON AND CONTAIN AMINOALKYL GROUPS | SMYD2, SCLY, SMYD3 | ALOX15 795/4885ALDH1A1 114/4885KMT2A 3257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.